Olfera
2 known investors
Find your way into Olfera
Sign up to see every warm intro you have to Olfera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Olfera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.
Investors · 2
E2MC Ventureslisted by E2MC VenturesOrlando · $250K – $2M
How we know: the VCSheet dataset · Not right? Tell us
Stellarlisted by StellarLos Altos
How we know: Stellar's portfolio page · Not right? Tell us
Frequently asked questions
- What does Olfera do?
- Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.
- Who are Olfera's investors?
- Olfera's investors include E2MC Ventures, Stellar.

